Headline
The latest stories from AHA Today.
The Food and Drug Administration released an FAQ on hospitals' utilization of home-use blood glucose meters during the COVID-19 health crisis.
The Centers for Medicare & Medicaid Services clarified that the agency is waiving the Medicare coverage requirement for a three-day prior hospitalization requirement for both skilled nursing facilities and swing-bed services.
The Department of Health and Human Services announced seven new ventilator production contracts to boost national availability. Five of the contracts are rated under the Defense Production Act, meaning they must be accepted and prioritized by the contractors.
Medicare will increase payment for certain "high-throughput" COVID-19 diagnostic tests to $100 to expand testing capacity and speed results during the public health emergency, the Centers for Medicare & Medicaid Services announced.
The Centers for Disease Control and Prevention reported an estimated 9,282 confirmed COVID-19 cases in U.S. health care workers between Feb. 12 and April 9, representing 19% of U.S. cases for which occupational status was available.
AHA joined hospital and health system leaders at a White House event to announce the Dynamic Ventilator Reserve, a public-private online initiative to track and help distribute available ventilators and associated supplies to high-need areas of the country.
The AHA has partnered with Microsoft, Kaiser Permanente, consulting firm Kearney, Merit Solutions and UPS to launch Protecting People Everywhere, an app-powered initiative that matches individuals and organizations donating personal protective equipment with local hospitals based on need.
The Centers for Disease Control and Prevention updated its infection prevention and control recommendations for patients with suspected or confirmed COVID-19 in health care settings.
The departments of Health and Human Services, Labor and Treasury April 11 issued joint guidance implementing legislative provisions specific to COVID-19 diagnostic testing and services.
The Food and Drug Administration Monday authorized emergency use of an infusion pump system to deliver nebulized medications to patients with or suspected of having COVID-19.